Fabio
3.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation; repealer | Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider and provides for accountability of such funds; provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing. | us/states/ny | New York Legislature | 2021-2022 | S 3762 | New York S 3762 (2021-2022) |
|
enacted |
|
1 | 14 | 3 | 2021-01-30 | 2021-12-31 | openstates | ocd-bill/5538989f-982a-4bbe-8a0f-103c18f3d6d2 | http://www.nysenate.gov/legislation/bills/2021/S3762 | f3cda2639e2aae7b4af8fe3a7f824c81e4678f4c9246f67196d948d466e00853 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York S 3762 (2021-2022) — Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation; repealer
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider and provides for accountability of such funds; provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- S3762 (committee substitute) — source
Votes
- Floor Vote — 62–1 (pass) · upper
- Assembly Vote — 149–0 (pass) · lower
- Health Vote — 15–0 (pass) · upper
Sponsors
- BRESLIN — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-30 REFERRED TO HEALTH
referral-committee - 2021-03-09 1ST REPORT CAL.543
- 2021-03-10 2ND REPORT CAL.
- 2021-03-11 ADVANCED TO THIRD READING
- 2021-03-17 PASSED SENATE
passage - 2021-03-17 DELIVERED TO ASSEMBLY
- 2021-03-17 REFERRED TO CODES
referral-committee - 2021-06-08 SUBSTITUTED FOR A1396
- 2021-06-08 ORDERED TO THIRD READING RULES CAL.531
- 2021-06-10 PASSED ASSEMBLY
passage - 2021-06-10 RETURNED TO SENATE
- 2021-12-20 DELIVERED TO GOVERNOR
executive-receipt - 2021-12-31 SIGNED CHAP.828
executive-signature - 2021-12-31 APPROVAL MEMO.166
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/5538989f-982a-4bbe-8a0f-103c18f3d6d2. Confidence: reported (aggregated from official New York legislature records).